The significance of interferon gamma inducible protein 16 (IFI16) expression in drug resistant ovarian cancer cell lines
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The significance of interferon gamma inducible protein 16 (IFI16) expression in drug resistant ovarian cancer cell lines
Authors
Keywords
Interferon gamma inducible protein 16 (IFI16), Isoforms, Ovarian cancer cell lines, Drug resistance, Histological type
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 150, Issue -, Pages 113036
Publisher
Elsevier BV
Online
2022-04-28
DOI
10.1016/j.biopha.2022.113036
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity
- (2020) Małgorzata Krześniak et al. CELLULAR SIGNALLING
- Adropin Stimulates Proliferation and Inhibits Adrenocortical Steroidogenesis in the Human Adrenal Carcinoma (HAC15) Cell Line
- (2020) Ewelina Stelcer et al. Frontiers in Endocrinology
- Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies
- (2020) Kathleen Wantoch von Rekowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations
- (2019) Świerczewska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells
- (2019) Kathleen Wantoch von Rekowski et al. Biomolecules
- IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway
- (2019) Hongning Cai et al. BIOMEDICINE & PHARMACOTHERAPY
- New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines
- (2018) Monika Świerczewska et al. MOLECULES
- The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines
- (2018) Karolina Sterzyńska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development
- (2018) Karolina Sterzyńska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines
- (2017) Monika Świerczewska et al. MOLECULES
- The significance of lumican expression in ovarian cancer drug-resistant cell lines
- (2017) Andrzej Klejewski et al. Oncotarget
- Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines
- (2017) Radosław Januchowski et al. Oncotarget
- IFI16, an amplifier of DNA-damage response: Role in cellular senescence and aging-associated inflammatory diseases
- (2016) Divaker Choubey et al. AGEING RESEARCH REVIEWS
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Characterization of ovarian cancer cell lines as in vivo models for preclinical studies
- (2016) Lidia Hernandez et al. GYNECOLOGIC ONCOLOGY
- Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines
- (2016) Radosław Januchowski et al. Journal of Ovarian Research
- Bisphenol A (BPA) stimulates the interferon signaling and activates the inflammasome activity in myeloid cells
- (2015) Ravichandran Panchanathan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The Extracellular Matrix in Epithelial Ovarian Cancer – A Piece of a Puzzle
- (2015) Angela Cho et al. Frontiers in Oncology
- IFI16: At the interphase between innate DNA sensing and genome regulation
- (2014) Martin R. Jakobsen et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- Platinum-Sensitive Recurrence in Ovarian Cancer: The Role of Tumor Microenvironment
- (2013) Jeremy Chien et al. Frontiers in Oncology
- The mammalian PYHIN gene family: Phylogeny, evolution and expression
- (2012) Jasmyn A Cridland et al. BMC EVOLUTIONARY BIOLOGY
- The tumor microenvironment is a dominant force in multidrug resistance
- (2012) Ana Luísa Correia et al. DRUG RESISTANCE UPDATES
- Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16
- (2012) T. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer
- (2011) Gavin C.E. Stuart et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- The Multifaceted Interferon-Inducible p200 Family Proteins: From Cell Biology to Human Pathology
- (2011) Marisa Gariglio et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: Regulation of subcellular localization
- (2011) Sudhakar Veeranki et al. MOLECULAR IMMUNOLOGY
- Interferon-Inducible Protein 16: Insight into the Interaction with Tumor Suppressor p53
- (2011) Jack C.C. Liao et al. STRUCTURE
- The interferon-inducible gene IFI16 secretome of endothelial cells drives the early steps of the inflammatory response
- (2010) Rossella Baggetta et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Interferon-Inducible p200-Family Proteins as Novel Sensors of Cytoplasmic DNA: Role in Inflammation and Autoimmunity
- (2010) Divaker Choubey et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- IFI16 is an innate immune sensor for intracellular DNA
- (2010) Leonie Unterholzner et al. NATURE IMMUNOLOGY
- Interferon-Inducible IFI16, a Negative Regulator of Cell Growth, Down-Regulates Expression of Human Telomerase Reverse Transcriptase (hTERT) Gene
- (2010) Lynda Li Song et al. PLoS One
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Identification of Genes With Differential Expression in Chemoresistant Epithelial Ovarian Cancer Using High-Density Oligonucleotide Microarrays
- (2009) Woong Ju et al. ONCOLOGY RESEARCH
- Nonplatinum Topotecan Combinations Versus Topotecan Alone for Recurrent Ovarian Cancer: Results of a Phase III Study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group
- (2008) Jalid Sehouli et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer
- (2008) Gabriella Ferrandina et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression of an IFN-Inducible Cellular Senescence Gene, IFI16, Is Up-Regulated by p53
- (2008) L. L. Song et al. MOLECULAR CANCER RESEARCH
- Interferon-inducible IFI16 protein in human cancers and autoimmune diseases
- (2007) Divaker Choubey Frontiers in Bioscience-Landmark
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search